vancomycin has been researched along with paclitaxel in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Kaul, M; Kelley, C; LaVoie, EJ; Parhi, A; Pilch, DS; Zhang, Y | 1 |
| Giurleo, D; Kaul, M; LaVoie, EJ; Parhi, A; Pilch, DS; Zhang, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chen, Y; Kirchmair, J; Li, X; Ma, G; Wu, S; Xia, J; Xue, W; Zhang, H | 1 |
| Arango, JI; Bradshaw, P; Callander, NS; Freytes, CO; Ochoa-Bayona, JL; Patterson, J; Restrepo, A; Restrepo, MI; Schneider, DL | 1 |
| Cegelski, L | 1 |
| Chen, X; Du, L; Liu, M | 1 |
1 review(s) available for vancomycin and paclitaxel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for vancomycin and paclitaxel
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agents.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cytoskeletal Proteins; Enterococcus faecalis; HEK293 Cells; Humans; Isoquinolines; Molecular Targeted Therapy; Staphylococcus aureus | 2012 |
Substituted 1,6-diphenylnaphthalenes as FtsZ-targeting antibacterial agents.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cytoskeletal Proteins; Enterococcus faecalis; Microbial Sensitivity Tests; Molecular Structure; Naphthalenes; Polymerization; Staphylococcus aureus | 2013 |
N-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification.
Topics: Animals; Anti-Bacterial Agents; DNA Gyrase; Drug Design; Enterococcus faecalis; Enterococcus faecium; Female; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Quinolones; Staphylococcus epidermidis; Structure-Activity Relationship; Thiadiazoles; Topoisomerase II Inhibitors | 2020 |
Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma.
Topics: Adult; Aged; Cephalosporins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Mobilization; Humans; Incidence; Lymphoma; Male; Middle Aged; Multiple Myeloma; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Risk Factors; Transplantation, Autologous; Vancomycin | 2006 |
REDOR NMR for drug discovery.
Topics: Anti-Bacterial Agents; Binding Sites; Drug Discovery; Humans; Microtubules; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Paclitaxel; Staphylococcal Infections; Staphylococcus aureus; Tubulin Modulators; Vancomycin | 2013 |
Development, validation, and application of an UPLC-MS/MS method for vancomycin, norvancomycin, methotrexate, paclitaxel, and imatinib analysis in human plasma.
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Imatinib Mesylate; Methotrexate; Paclitaxel; Reproducibility of Results; Tandem Mass Spectrometry; Vancomycin | 2022 |